 | Up a level |
2021
Ferreira, Arlindo R., Ferreira, Sofia, Lambertini, Matteo 
ORCID: 0000-0003-1797-5296, Maurer, Christian, Martel, Samuel, Costa, Luis, Ponde, Noam and de Azambuja, Evandro ORCID: 0000-0001-9501-4509
(2021).
Association between pertuzumab-associated diarrhoea and rash and survival outcomes in patients with HER2-positive metastatic breast cancer: Exploratory analysis from the CLEOPATRA trial.
Eur. J. Cancer, 144.
S. 351 - 360.
OXFORD:
ELSEVIER SCI LTD.
ISSN 1879-0852
2020
Ferreira, Arlindo R., Ponde, Noam, Lambertini, Matteo, Maurer, Christian, Martel, Samuel, Costa, Luis and De Azambuja, Evandro (2020). Association between pertuzumab (P) induced diarrhea and skin rash and survival outcomes in patients (pts) with HER2-positive metastatic breast cancer enrolled in the CLEOPATRA trial. Cancer Res., 80 (4). PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1538-7445
2018
Martel, Samuel, Bruzzone, Marco ORCID: 0000-0002-8821-4542, Ceppi, Marcello ORCID: 0000-0002-8177-8003, Maurer, Christian, Ponde, Noam Falbel, Ferreira, Arlindo R., Viglietti, Giulia, Del Mastro, Lucia ORCID: 0000-0002-9546-5841, Prady, Catherine, de Azambuja, Evandro ORCID: 0000-0001-9501-4509 and Lambertini, Matteo ORCID: 0000-0003-1797-5296
(2018).
Risk of adverse events with the addition of targeted agents to endocrine therapy in patients with hormone receptor-positive metastatic breast cancer: A systematic review and meta-analysis.
Cancer Treat. Rev., 62.
S. 123 - 133.
OXFORD:
ELSEVIER SCI LTD.
ISSN 1532-1967
Maurer, Christian, Ferreira, Arlindo R., Martel, Samuel, Lambertini, Matteo ORCID: 0000-0003-1797-5296, Ponde, Noam, Aftimos, Philippe, de Azambuja, Evandro ORCID: 0000-0001-9501-4509 and Piccart, Martine
(2018).
Endocrine therapy and palbociclib within a compassionate use program in heavily pretreated hormone receptor-positive, HER2-negative metastatic breast cancer.
Breast, 39.
S. 14 - 19.
EDINBURGH:
CHURCHILL LIVINGSTONE.
ISSN 1532-3080